GO
Loading...

Gilead Sciences Inc

More

  • Cramer: How to make money in wild market swings Wednesday, 4 Feb 2015 | 6:13 PM ET
    Al Pacino portrays Tony Montana, a Cuban immigrant turned kingpin, in a scene from the film "Scarface."

    Jim Cramer thinks this market is like the movie "Scarface." He teaches investors how to make money in a wild market.

  • NEW YORK, Feb 4- The euro slumped late on Wednesday and safe-haven U.S. government bonds rallied after the European Central Bank abruptly canceled its acceptance of Greek bonds in return for funding, putting more pressure on Greece to reach new reforms. In an indication of how Greek equities might trade on Thursday morning, the Global X FTSE Greece...

  • GLOBAL MARKETS-Euro slumps after sudden ECB action Wednesday, 4 Feb 2015 | 5:08 PM ET

    NEW YORK, Feb 4- The euro slumped late on Wednesday while the U.S. dollar surged after the European Central Bank abruptly canceled its acceptance of Greek bonds in return for funding, shifting the burden onto Athens' central bank to finance its lenders and isolating Greece unless it reaches a new reform deal. The move, which means that the Greek central bank will...

  • NEW YORK, Feb 4- The S&P 500 and Nasdaq ended lower on Wednesday, snapping a two-day rally as energy shares slid with oil prices and as investors' anxiety about the euro zone returned in the closing minutes of trading. The benchmark index added to losses late in the session after the European Central Bank abruptly canceled its acceptance of Greek bonds in return for...

  • NEW YORK, Feb 4- The S&P 500 and Nasdaq eased on Wednesday in the wake of a two-day rally as energy shares followed oil prices lower and Gilead and other biotech names declined. Walt Disney kept the Dow in positive territory. Disney shares jumped 8 percent to $101.64 after quarterly profit topped analysts' expectations.

  • *Japanese equities rise on strong Mitsubishi results. NEW YORK, Feb 4- The U.S. dollar rebounded on Wednesday from its worst day in more than a year, while a retreat in oil prices pressured energy shares and weighed on Wall Street. Encouraging economic data out of the United States and Europe and optimism about Greece's debt negotiations drove up U.S. bond yields for...

  • NEW YORK, Feb 4- The S&P 500 and Nasdaq eased on Wednesday, in the wake of a two-day rally, as Gilead and other biotech names declined and energy shares reversed course with oil prices. Walt Disney kept the Dow in positive territory. Leading biotechnology shares lower was Gilead Sciences, whose stock dropped 7.5 percent, a day after the drugmaker said it is offering...

  • Wednesday's midday movers: Comcast, Apple & more Wednesday, 4 Feb 2015 | 12:16 PM ET
    Traders on the floor of the New York Stock Exchange.

    Take a look at some of Wednesday's midday movers:

  • Pricing wars heat up over hepatitis C drugs Wednesday, 4 Feb 2015 | 12:13 PM ET
    A researcher works on a hepatitis C virus drug at Gilead Sciences lab in Foster City, Calif.

    Discounts on Gilead's hepatitis C drugs this year will be 46 percent, way more than investors and analysts expected.

  • Gilead drags healthcare shares down on drug price worries Wednesday, 4 Feb 2015 | 11:38 AM ET

    Feb 4- Healthcare shares plunged on Wednesday, lead by biotechnology stocks, after Gilead Sciences Inc said it gave health insurers steeper-than-expected discounts on its hepatitis C drugs, fueling worries that the broader sector would face increasing price pressure. Gilead weighed most heavily on the biotechnology sector with a 8.9 percent drop in its...

  • *Crude falls after 4- day rally. NEW YORK, Feb 4- U.S. stocks dipped on Wednesday, in the wake of a two-day rally for the S&P 500, as oil prices declined and labor market data disappointed. U.S. crude was down 5.1 percent to $50.37 and Brent was off 3.6 percent to $55.83.

  • Gilead profit quadruples on $3.84B in hep C sales Wednesday, 4 Feb 2015 | 10:51 AM ET
    A scientist at Gilead Sciences analyzes patient antibody levels at the Gilead laboratory in Foster City, California.

    Gilead Sciences posted strong sales of its hepatitis C drugs Harvoni and Sovaldi, sending its net profit up more than four-fold for the quarter.

  • *Crude falls after 4- day rally. NEW YORK, Feb 4- U.S. stocks lost ground in early trade on Wednesday, in the wake of a two-day rally for the S&P 500, as oil prices declined and labor market data disappointed. U.S. crude was down 3.3 percent to $51.32 and Brent was off 2.6 percent to $56.43.

  • Merck's hep C drugs to lose breakthrough status Wednesday, 4 Feb 2015 | 9:19 AM ET
    Scientist Kate Lipford evaporates solvents in the research lab at Merck in the Longwood medical district.

    Merck said the U.S. FDA intends to rescind its "breakthrough" designation for its experimental combination treatment for hep C.

  • NEW YORK, Feb 4- U.S. stocks were poised to dip at the open on Wednesday, in the wake of a two-day rally for the S&P 500, as oil prices declined and labor market data disappointed. U.S. crude was down 3.3 percent to $51.32 and Brent was off 2.6 percent to $56.43. Contract driller Transocean fell 1.9 percent to $18.05 in premarket trade.

  • Early movers: ODP, SPLS, GM, MRK, ADP & more Wednesday, 4 Feb 2015 | 8:06 AM ET
    A trader works on the floor of the New York Stock Exchange, Oct. 31, 2014.

    Some of the names on the move ahead of the open.

  • US STOCKS-Futures dip after 2-day run; ADP data on tap Wednesday, 4 Feb 2015 | 7:43 AM ET

    NEW YORK, Feb 4- U.S. stock index futures dipped on Wednesday, after a two-day rally for the S&P 500 ahead of data on the labor market and the services sector. *Investors will eye the January private-sector employment report from payrolls processor ADP at 8:15 a.m. for signs of continuing improvement in the labor market. *Later in the session at 9:45 a.m., financial...

  • 6 earnings trades on Chipotle, Disney and Gilead Tuesday, 3 Feb 2015 | 7:10 PM ET

    "Fast Money" traders looked at how to play Chipotle, Walt Disney and Gilead, key players in three diverse sectors.

  • Feb 3- Gilead Sciences Inc on Tuesday said it is offering steeper-than-expected discounts on its hepatitis C drugs to health insurers and other group payers who had complained about the price, and the drugmaker's shares slid more than 5 percent. Gilead executives disclosed the discounts on a conference call after the company said strong sales of the drugs,...

  • After-hours buzz: Chipotle, Disney, Gilead & more Tuesday, 3 Feb 2015 | 5:22 PM ET
    Pedestrians cross the street in front of the Macy's Inc. flagship store in New York.

    Check out which companies are making headlines after the bell Tuesday: Chipotle, Disney, Gilead & more.